Ana Royuela

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · The Lancet Oncology · 2020 · 788 citations

Medicine, Immune Checkpoint Inhibitor, Cancer Treatment +4

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal et al. · Journal of Clinical Oncology · 2022 · 322 citations · Full text

Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain

Francisco M. Kovacs, Víctor Abraira, Ana Royuela et al. · BMC Musculoskeletal Disorders · 2008 · 266 citations · Full text

Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio

Sergio Serrano‐Villar, Maria Jesús Pérez‐Elías, Fernando Dronda et al. · PLoS ONE · 2014 · 202 citations · Full text

Minimal Clinically Important Change for Pain Intensity and Disability in Patients With Nonspecific Low Back Pain

Francisco M. Kovacs, Víctor Abraira, Ana Royuela et al. · Spine · 2007 · 202 citations